Weight Loss Injections and an Underactive Thyroid: What You Need to Ask First

Are weight loss injections safe to use when you have hypothyroidism?

For the vast majority of people with a well-controlled underactive thyroid, the evidence does not suggest GLP-1 receptor agonists such as tirzepatide or semaglutide are unsafe. The NHS guidance on weight loss injections does not list hypothyroidism as a contraindication. What it does highlight is that these medicines are prescription-only and require clinical assessment, which means a prescriber looks at your complete medical picture, including your thyroid history and your current thyroid function.

That said, hypothyroidism does create a particular context worth understanding. An underactive thyroid that is poorly controlled or undertreated can itself cause weight gain, fluid retention, fatigue and a generally slower metabolism. If your thyroid function is not optimised, you may find weight loss slower than trial averages suggest, not because the injection is failing, but because thyroid hormone levels are working against you. Getting a recent thyroid function test result to hand before a consultation is genuinely useful.

The clinical trials for tirzepatide (SURMOUNT-1, published in the New England Journal of Medicine) and semaglutide did not exclude participants with treated hypothyroidism, which gives clinicians reasonable real-world data to draw on. That is reassuring, even if those trials were not designed to isolate thyroid-specific outcomes.

What is the thyroid cancer caution, and does it apply to most people?

This is the question people with any thyroid history ask most often, and it deserves a clear answer. Both Mounjaro and Wegovy carry a precautionary note about medullary thyroid carcinoma (MTC) and multiple endocrine neoplasia type 2 (MEN2). These are specific, relatively rare conditions. The caution arises from animal studies showing thyroid C-cell tumours at high doses, it has not been demonstrated in humans, but as a precaution, anyone with a personal or family history of MTC or MEN2 should not use these medicines. The SmPC for tirzepatide published on the electronic Medicines Compendium sets this out clearly.

Ordinary hypothyroidism (the far more common condition where the thyroid simply produces too little hormone) is a different matter entirely. It is not MTC. A prescriber will ask about your thyroid history specifically to distinguish between these situations. If you have had thyroid surgery, radioiodine treatment, or a thyroid nodule, bring those details to your consultation. They help the prescriber make the right call, but they do not automatically close the door.

For more on how thyroid conditions interact with this class of medicines, our page covering weight loss injections and thyroid cancer history goes into the MTC distinction in more detail.

Could weight loss injections affect your levothyroxine?

This is the practical, day-to-day question that often gets missed. Most people with hypothyroidism take levothyroxine, usually first thing in the morning on an empty stomach. Both Mounjaro and Wegovy slow gastric emptying, that is part of how they work. Slower gastric emptying can, in theory, alter the absorption rate of other oral medicines, including levothyroxine.

Whether this produces a clinically meaningful change in thyroid hormone levels varies between individuals. If you want a broader picture of how these medicines interact with thyroid conditions, our guide on weight loss injections and thyroid health covers the key considerations in one place. Your GP, who manages your levothyroxine dose, should be notified when you begin a GLP-1 injection, both because of this interaction possibility and because GP notification is in line with GPhC guidance for responsible online prescribing.

In practical terms, this means your thyroid function may need monitoring more closely in the first months of treatment, particularly around dose increases when gastric slowing is at its most pronounced. If you feel more fatigued than usual, or notice symptoms that feel like undertreated hypothyroidism, that warrants a conversation with your GP rather than a self-adjustment of either medicine.

Who should you speak to, and what should you bring to that conversation?

The honest answer is that suitability depends on your individual situation, your current thyroid function results, your levothyroxine dose, any other conditions, and what your BMI and weight history look like. A prescriber cannot assess this from a leaflet, and neither can this page. What it can do is help you arrive at that conversation well-prepared.

Useful things to have ready: a recent thyroid function test (TSH and free T4 if possible), a list of all current medicines including supplements, and clarity on your BMI. Our general eligibility guide covers the licensed criteria for Mounjaro and Wegovy in more detail. For people specifically navigating weight loss injections as a thyroid patient, there are additional practical considerations worth reading before your consultation.

At nume, every consultation is reviewed the same day by a named GPhC-registered Independent Prescriber, a real clinician reads your answers, not automated software. If treatment is clinically suitable and you order before midday on a working day, it is dispatched the same day and delivered free the next working day via DPD in plain packaging. If you are ready to find out where you stand, check your eligibility through our free consultation.